Structure Therapeutics' (GPCR) subsidiary Gasherbrum Bio signed a patent license agreement with Genentech, granting Genentech ...

Structure Therapeutics, Inc. Sponsored ADR ( ($GPCR) ) has issued an update. On December 30, 2025, Gasherbrum Bio, a subsidiary of Structure ...

SAN MATEO, Calif., and CAMBRIDGE, Mass., Jan. 25, 2024 (GLOBE NEWSWIRE) -- Kronos Bio, Inc. (Nasdaq: KRON), a company dedicated to transforming the lives of those affected by cancer, today announced a ...

Featuring one of the most experienced teams in the field of Structural Biology, Creative BioStructure offers a full range of structural services, from molecular cloning to three-dimensional protein ...

Shouti Inc. has established subsidiary Basecamp Bio to navigate the complex challenges of membrane protein structure-based drug discovery. Using Shanghai and San Francisco-based Shouti’s drug ...